ConvaTec launches Cure Aqua. ConvaTec stock gains 1.56 percent
Published on 10/05/2026 at 14:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
ConvaTec (ISIN GB00BD3VFW73) was trading at EUR 2.61 at Lang & Schwarz on October 5, 2026 at 2:07 p.m. CEST, up 1.56 percent versus the prior close of EUR 2.57. On September 28, 2026, Business Wire reported that the company launched Cure Aqua in the United States and Canada. The ready-to-use hydrophilic catheter expands ConvaTec's Cure portfolio and gives the continence business a new product entry point.
Cure Aqua adds a new product
Cure Aqua is designed for intermittent catheterization and requires no activation step, according to Business Wire. The company lists female, male and pediatric versions, while the product also includes a no-touch handling sleeve and packaging designed for privacy.
The launch matters because it broadens the product range in a business that is already producing measurable growth. Medical Tubing and Extrusion reported that continence care revenue reached USD 277 million in the first half of 2026, up 6.60 percent from the same period of 2025. Sales of GentleCath Air for women had more than doubled, the report said.
Buyback reduces the share count
Capital returns provide a second measurable support for the investment case. According to Investegate, ConvaTec purchased 5,226,866 ordinary shares between September 21 and September 25, 2026 under a buyback program of up to USD 200 million. The repurchased shares are held in treasury, and the company reported 1,917,324,740 ordinary shares in issue after the transactions.
Analysts see room above the price
Valuation expectations remain higher than the London quotation. MarketBeat reported on September 28, 2026 that eight of nine covering brokers rated the stock Buy and one rated it Hold, with an average 12-month target of GBp 305.44. The same report listed a 52-week LSE range of GBp 193.00 to GBp 259.30, placing the London share below that high at the quoted date.
Stock gains in afternoon trading
ConvaTec stock was trading at EUR 2.61 at Lang & Schwarz on October 5, 2026 at 2:07 p.m. CEST, compared with the Lang & Schwarz prior close of EUR 2.57 on October 2, 2026. The primary listing is on the London Stock Exchange under ticker CTEC, and the company is a FTSE 100 constituent.
The further course of trading is shown by the continuously updated real-time quote of ConvaTec stock.
ConvaTec market facts
- Company: ConvaTec Group Plc
- ISIN: GB00BD3VFW73
- Ticker: CTEC
- Primary exchange: London Stock Exchange
- Price Lang & Schwarz (as of October 5, 2026, 2:07 p.m. CEST): EUR 2.61
- Change versus prior close: plus 1.56 percent
- Prior close Lang & Schwarz (October 2, 2026): EUR 2.57
- Market capitalization: USD 5.6 billion (as of October 2, 2026)
- Sector / Industry: Healthcare / Medical Instruments and Supplies
- Index membership: FTSE 100
